{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:13:24Z","timestamp":1794255204089,"version":"4.9.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Transplant-associated thrombotic microangiopathy (TA-TMA) is a severe complication of hematopoietic stem cell transplantation (HSCT). A single-center prospective screening study has shown that the incidence of TA-TMA is much higher than prior retrospective studies that did not systematically screen. These data have not been replicated in a multicenter study. Our objective was to determine the incidence and risk factors for TA-TMA and compare outcomes of pediatric HSCT patients with and without TA-TMA. Patients were prospectively screened for TA-TMA at participating centers using a simple to implement and inexpensive strategy from the start of the preparative regimen through day +100. TA-TMA was diagnosed if \u22654 of 7 laboratory\/clinical markers diagnostic for TA-TMA were present concurrently or if tissue histology showed TA-TMA. A total of 614 patients (359 males; 58%) received prospective TA-TMA screening at 13 pediatric centers. TA-TMA was diagnosed in 98 patients (16%) at a median of 22 days (interquartile range, 14-44) posttransplant. Patients with TA-TMA had significantly increased bloodstream infections (38% [37\/98] vs 21% [107\/51], P \u2264 .001), mean total hospitalization days (68; 95% confidence interval [CI], 63-74 vs 43; 95% CI, 41-45; P \u2264 .001), and number of days spent in the intensive care unit (10.1; 95% CI, 6.4-14; vs 1.6; 95% CI, 1.1-2.2; P \u2264 .001) in the first 100 days after HSCT compared with patients without TA-TMA. Overall survival was significantly higher in patients without TA-TMA (93%; 490\/516) compared with patients with TA-TMA (78%; 76\/98) (P \u2264 .001). These data support the need for systematic screening for TA-TMA and demonstrate the feasibility and efficacy of an easy to implement strategy to do so.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020003455","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T17:00:43Z","timestamp":1608742843000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":92,"title":["A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4001-9203","authenticated-orcid":false,"given":"Christopher E.","family":"Dandoy","sequence":"first","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Rotz","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Badia","family":"Alonso","sequence":"additional","affiliation":[{"name":"Center for Cancer and Blood Disorders, Phoenix Children\u2019s Hospital, Phoenix, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Klunk","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1000-6620","authenticated-orcid":false,"given":"Catherine","family":"Desmond","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Huber","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Ingraham","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Higham","sequence":"additional","affiliation":[{"name":"Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, Benioff Children\u2019s Hospital, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-3952","authenticated-orcid":false,"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[{"name":"Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, Benioff Children\u2019s Hospital, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Duncan","sequence":"additional","affiliation":[{"name":"Dana Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard University, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Schoettler","sequence":"additional","affiliation":[{"name":"Dana Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard University, Boston, MA;"},{"name":"Children\u2019s Healthcare of Atlanta\/Aflac Cancer and Blood Disorders Center, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Lehmann","sequence":"additional","affiliation":[{"name":"Dana Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard University, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cancio","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6218-1500","authenticated-orcid":false,"given":"James","family":"Killinger","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8281-3627","authenticated-orcid":false,"given":"Blachy","family":"Davila","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Children\u2019s National Hospital, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Phelan","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris M.","family":"Mahadeo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Children\u2019s Cancer Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3731-608X","authenticated-orcid":false,"given":"Sajad","family":"Khazal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Children\u2019s Cancer Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahal","family":"Lalefar","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology\/Bone Marrow Transplantation, University of California San Fransisco Benioff Children's Hospital Oakland, Oakland, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav","family":"Vissa","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology\/Bone Marrow Transplantation, University of California San Fransisco Benioff Children's Hospital Oakland, Oakland, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasiani","family":"Myers","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Wallace","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Nelson","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Khandelwal","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Bhatla","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, SSM Health Cardinal Glennon Children\u2019s Hospital, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Gloude","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California San Diego, Rady Children\u2019s Hospital San Diego, San Diego, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3665-3102","authenticated-orcid":false,"given":"Eric","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California San Diego, Rady Children\u2019s Hospital San Diego, San Diego, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0057-9118","authenticated-orcid":false,"given":"Jeffrey","family":"Huo","sequence":"additional","affiliation":[{"name":"Pediatric Blood and Marrow Transplantation, Levine Children\u2019s Cancer and Blood Disorders, Atrium Health, Charlotte, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Roehrs","sequence":"additional","affiliation":[{"name":"Pediatric Blood and Marrow Transplantation, Levine Children\u2019s Cancer and Blood Disorders, Atrium Health, Charlotte, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery J.","family":"Auletta","sequence":"additional","affiliation":[{"name":"Host Defense Program and Blood and Marrow Transplant Program, Nationwide Children\u2019s Hospital, Columbus, OH;"},{"name":"Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Chima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"},{"name":"Division of Critical Care and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lane","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"},{"name":"Division of Biostatistics, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonata","family":"Jodele","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"issue":"3","key":"2020122316403933700_B1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4067\/S0716-97602012000300012","article-title":"Hematopoietic stem cell transplantation: clinical use and perspectives","volume":"45","author":"Barriga","year":"2012","journal-title":"Biol Res"},{"issue":"17","key":"2020122316403933700_B2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"2020122316403933700_B3","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.bbmt.2011.05.001","article-title":"Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study","volume":"17","author":"Remberger","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2020122316403933700_B4","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","article-title":"Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation","volume":"21","author":"El-Bietar","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2020122316403933700_B5","doi-asserted-by":"crossref","first-page":"e26513","DOI":"10.1002\/pbc.26513","article-title":"Team-based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipients","volume":"64","author":"Dandoy","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2020122316403933700_B6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/bmt.2014.40","article-title":"Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy","volume":"49","author":"Lerner","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2020122316403933700_B7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/bmt.2016.331","article-title":"Pericardial effusion requiring surgical intervention after stem cell transplantation: a case series","volume":"52","author":"Pfeiffer","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2020122316403933700_B8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"issue":"8","key":"2020122316403933700_B9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"issue":"4","key":"2020122316403933700_B10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/bmt.2009.230","article-title":"Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning","volume":"45","author":"Willems","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2020122316403933700_B11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.tp.0000297998.33418.7e","article-title":"Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study","volume":"85","author":"Siami","year":"2008","journal-title":"Transplantation"},{"issue":"6","key":"2020122316403933700_B12","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2020122316403933700_B13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"2020122316403933700_B14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fped.2019.00133","article-title":"Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management","volume":"7","author":"Dvorak","year":"2019","journal-title":"Front Pediatr"},{"issue":"10","key":"2020122316403933700_B15","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41409-018-0159-8","article-title":"High-dose carboplatin\/etoposide\/melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma","volume":"53","author":"Jodele","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2020122316403933700_B16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbmt.2015.10.002","article-title":"Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"2020122316403933700_B17","first-page":"1049","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"issue":"8","key":"2020122316403933700_B18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"2020122316403933700_B19","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"issue":"4 Pt 2","key":"2020122316403933700_B20","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1475-6773.2006.00567.x","article-title":"Creating high reliability in health care organizations","volume":"41","author":"Pronovost","year":"2006","journal-title":"Health Serv Res"},{"key":"2020122316403933700_B21","volume-title":"The Improvement Guide: A Practical Approach To Enhancing Organizational Performance","author":"Langley","year":"2009"},{"issue":"9","key":"2020122316403933700_B22","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1016\/S2352-3026(17)30108-4","article-title":"EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis","volume":"4","author":"Luft","year":"2017","journal-title":"Lancet Haematol"},{"issue":"2","key":"2020122316403933700_B23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.transci.2016.04.007","article-title":"New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"54","author":"Jodele","year":"2016","journal-title":"Transfus Apheresis Sci"},{"issue":"1","key":"2020122316403933700_B24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbmt.2014.09.028","article-title":"Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy","volume":"21","author":"Dandoy","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"2020122316403933700_B25","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020122316403933700_B26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"10","key":"2020122316403933700_B27","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1182\/blood-2006-12-041889","article-title":"How I treat refractory acute GVHD","volume":"109","author":"Deeg","year":"2007","journal-title":"Blood"},{"issue":"9","key":"2020122316403933700_B28","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/pbc.24559","article-title":"Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review","volume":"60","author":"Mateos","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2020122316403933700_B29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10875-020-00789-4","article-title":"Thinking beyond HLH: clinical features of patients with concurrent presentation of hemophagocytic lymphohistiocytosis and thrombotic microangiopathy","volume":"40","author":"Gloude","year":"2020","journal-title":"J Clin Immunol"},{"issue":"10","key":"2020122316403933700_B30","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.bbmt.2019.06.006","article-title":"Risk factors for transplant-associated thrombotic microangiopathy after autologous hematopoietic cell transplant in high-risk neuroblastoma","volume":"25","author":"Tolbert","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2020122316403933700_B31","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/j.bbmt.2018.12.840","article-title":"Thrombotic microangiopathy following pediatric autologous hematopoietic cell transplantation: a report of significant end-organ dysfunction in eculizumab-treated survivors","volume":"25","author":"Schoettler","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"2020122316403933700_B32","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bbmt.2016.06.002","article-title":"Healthcare burden, risk factors, and outcomes of mucosal barrier injury laboratory-confirmed bloodstream infections after stem cell transplantation","volume":"22","author":"Dandoy","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2020122316403933700_B33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbmt.2012.08.022","article-title":"Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"19","author":"Jodele","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2020122316403933700_B34","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2013.07.017","article-title":"Pulmonary hypertension after hematopoietic stem cell transplantation","volume":"19","author":"Dandoy","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2020122316403933700_B35","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.5858\/arpa.2016-0599-RA","article-title":"A complete histologic approach to gastrointestinal biopsy from hematopoietic stem cell transplant patients with evidence of transplant-associated gastrointestinal thrombotic microangiopathy","volume":"141","author":"Warren","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"2020122316403933700_B36","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood-2013-07-512707","article-title":"TMA: beware of complements","volume":"122","author":"Ricklin","year":"2013","journal-title":"Blood"},{"issue":"12","key":"2020122316403933700_B37","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMc1700185","article-title":"ST2 and endothelial injury as a link between GVHD and microangiopathy","volume":"376","author":"Rotz","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"2020122316403933700_B38","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/bloodadvances.2018020321","article-title":"Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD","volume":"2","author":"Wall","year":"2018","journal-title":"Blood Adv"},{"issue":"5","key":"2020122316403933700_B39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1740774515598334","article-title":"Exploring the ethical and regulatory issues in pragmatic clinical trials","volume":"12","author":"Califf","year":"2015","journal-title":"Clin Trials"},{"issue":"5","key":"2020122316403933700_B40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jclinepi.2008.12.011","article-title":"A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers","volume":"62","author":"Thorpe","year":"2009","journal-title":"J Clin Epidemiol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/1\/1\/1795878\/advancesadv2020003455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/1\/1\/1795878\/advancesadv2020003455.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T17:01:18Z","timestamp":1608742878000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/1\/1\/474767\/A-pragmatic-multi-institutional-approach-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020003455","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,23]]}}}